Overview
In the rapidly evolving pharmaceutical landscape, value-added medicines (VAMs) are emerging as pivotal solutions that optimize patient outcomes and health care efficiency. These innovative products, which include reformulated, repurposed, or combined therapies, enhance existing medications’ efficacy, safety, and convenience.
This webinar will include examples of successful developments of value-added medicines in Europe, aiming to provide an in-depth exploration of the key regulatory and development aspects of value-added medicines, with a focus on the European context.
What You Will Learn
1. Regulatory Frameworks And Pathways In Europe
· Understanding the European regulatory environment for VAMs.
Navigating regulatory challenges and opportunities.
· Case studies illustrating successful regulatory strategies and approvals within Europe.
2. Development Strategies
· Key considerations in the development of VAMs, including formulation science, clinical trial design, and patient-centric approaches.
· Innovations in drug delivery systems and their impact on the development process.
